Science of Behavior Change
Frequently Asked Questions for Science of Behavior Change FOAs
8. Who are appropriate subjects, and what is an appropriate setting, for this research? Does the work on medical regimen adherence need to be conducted in individuals for whom specific medical regimens have been prescribed or recommended?
13. Can an institution/research team submit more than one application to a one RFA or submit an application to more than one of these companion RFAs (i.e., one interpersonal and social processes project and one self-regulation project)?
14. The UH2/UH3 RFAs mention the need to focus on targets relevant to two (or more) health behaviors relevant to two (or more) clinical endpoints or conditions. How are these targets, behaviors and endpoints supposed to be related?
FAQs Specific to the U01 Resource and Coordinating Center (RCC) RFA (RFA-RM-14-017)
- Conducting systematic reviews and meta-analyses of existing clinical trial reports and archived data sets, and using these sources to generate testable hypotheses concerning potential putative intervention targets, differential response of individuals to treatment, and estimates of intervention efficacy and effectiveness.
- All aspects of behavior change research and NIH-approved Good Clinical Practices (see http://www.nhlbi.nih.gov/research/funding/research-support/crg/managemen... for more information) as well as ethical issues related to clinical research.
- Facilitating cooperation between basic and clinical scientists and in behavioral intervention development.
- Helping to take research questions from hypothesis to implementation and the ability to document these processes.
- Study design and statistics, particularly with novel designs and methods that could enhance the efficiency of validation studies and behavioral trial designs.
- Creativity and innovation in solving technical and project challenges, as well as coordinating efforts among disparate research communities.
- The three target domains (self-regulation; stress reactivity and stress resilience; interpersonal and social processes) sufficient to participate as a member of the subcommittee for that target domain and ensure that products produced by target domain subcommittees will be suitable for the first three objectives of the RCC.
Questions generated from the January 21, 2015 Webinar
42. Please clarify what is meant by basic in the RFA where it notes that "both basic and clinical scientist" are required for the UH2/UH3 teams? Does basic here mean testing human blood and/or tissues, research in animals, or something else?